{"title": "New England Journal of Medicine Publishes Efficacy and Safety Data for GARDASIL\u00ae in Males", "author": null, "url": "https://www.fiercepharma.com/pharma/new-england-journal-of-medicine-publishes-efficacy-and-safety-data-for-gardasil%C2%AE-males", "hostname": "fiercepharma.com", "description": "WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (known as MSD outside the United States and Canada) announced today that data from the pivotal Phase III study with GARDASIL\u00ae [Human Papillomavirus | WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (known as MSD outside the United States and Canada) announced today that data from the pivotal Phase III study with GARDASIL\u00ae [Human Papillomavirus", "sitename": "FiercePharma", "date": "2011-02-02", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}